FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024332171> ?p ?o ?g. }

• W2024332171 endingPage "801" @default.
• W2024332171 startingPage "791" @default.
• W2024332171 abstract "The importance of alterations of the Her-2/neu oncogene in the tumorigenesis of Barrett's adenocarcinoma (BCA) is discussed controversially. In the present study, we evaluated for the first time the Her-2/neu status in the metaplasia-dysplasia-adenocarcinoma sequence of BCA simultaneously at the DNA, mRNA, and protein level using resection specimens of 25 patients. The locus-specific Her-2/neu gene status was quantified by performing fluorescence in situ hybridization, and information about the ploidy status of chromosome 17 was obtained. Tissue sections from the same areas were used for quantitative RT-PCR (TaqMan RT-PCR) of laser-microdissected tumor cells and for immunohistochemistry to quantify Her-2/neu mRNA and oncoprotein expression. Her-2/neu gene amplification was observed in 35% of BCA, and all of these samples showed strong overexpression of both mRNA and oncoprotein. A polysomy 17 without Her-2/neu gene amplification was observed in 52% of BCA, showing a normal or moderately elevated mRNA expression and no or weak immunopositivity. From 13 areas of high-grade dysplasia (HGD) we found four to be amplified for the Her-2/neu locus, whereas five showed a polysomy 17. All four samples of HGD areas with Her-2/neu gene amplification displayed mRNA and strong oncoprotein overexpression; however, lower mRNA levels were seen than in the amplified BCA areas. None of the samples with low-grade dysplasia (LGD) showed a locus-specific Her-2/neu amplification, but polysomy 17 was present in four of eight cases. No changes were detected in BCA-associated intestinal metaplasia and squamous epithelium. In summary, only a locus-specific Her-2/neu gene amplification was associated with strong mRNA overexpression and strong membranous Her-2/neu immunostaining in BCA and HGD. A chromosome 17 polysomy, as found in the majority of BCA, led to no or weak mRNA overexpression and no or weak immunopositivity. In the metaplasia-dysplasia-adenocarcinoma sequence, a chromosome 17 polysomy without Her-2/neu gene amplification was already present in LGD. This may be a result of an early polyploidization, preceding the later genetic events, such as Her-2/neu gene amplification in HGD and BCA." @default.
• W2024332171 created "2016-06-24" @default.
• W2024332171 creator A5003604913 @default.
• W2024332171 creator A5024097119 @default.
• W2024332171 creator A5025385520 @default.
• W2024332171 creator A5027041388 @default.
• W2024332171 creator A5041025031 @default.
• W2024332171 creator A5052307289 @default.
• W2024332171 creator A5062987908 @default.
• W2024332171 creator A5063110207 @default.
• W2024332171 creator A5069666525 @default.
• W2024332171 creator A5074211261 @default.
• W2024332171 creator A5090628379 @default.
• W2024332171 date "2001-06-01" @default.
• W2024332171 modified "2023-10-12" @default.
• W2024332171 title "Her-2/neu Gene Amplification, Elevated mRNA Expression, and Protein Overexpression in the Metaplasia-Dysplasia-Adenocarcinoma Sequence of Barrett's Esophagus" @default.
• W2024332171 cites W1573413333 @default.
• W2024332171 cites W1984626101 @default.
• W2024332171 cites W1986927287 @default.
• W2024332171 cites W1989856647 @default.
• W2024332171 cites W2003173259 @default.
• W2024332171 cites W2036231003 @default.
• W2024332171 cites W2049627851 @default.
• W2024332171 cites W2076440683 @default.
• W2024332171 cites W2112750808 @default.
• W2024332171 cites W2130629350 @default.
• W2024332171 cites W2141513637 @default.
• W2024332171 cites W2144958249 @default.
• W2024332171 cites W2145684092 @default.
• W2024332171 cites W2161428561 @default.
• W2024332171 cites W2164578725 @default.
• W2024332171 doi "https://doi.org/10.1038/labinvest.3780289" @default.
• W2024332171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11406641" @default.
• W2024332171 hasPublicationYear "2001" @default.
• W2024332171 type Work @default.
• W2024332171 sameAs 2024332171 @default.
• W2024332171 citedByCount "55" @default.
• W2024332171 countsByYear W20243321712012 @default.
• W2024332171 countsByYear W20243321712013 @default.
• W2024332171 countsByYear W20243321712014 @default.
• W2024332171 countsByYear W20243321712015 @default.
• W2024332171 countsByYear W20243321712017 @default.
• W2024332171 crossrefType "journal-article" @default.
• W2024332171 hasAuthorship W2024332171A5003604913 @default.
• W2024332171 hasAuthorship W2024332171A5024097119 @default.
• W2024332171 hasAuthorship W2024332171A5025385520 @default.
• W2024332171 hasAuthorship W2024332171A5027041388 @default.
• W2024332171 hasAuthorship W2024332171A5041025031 @default.
• W2024332171 hasAuthorship W2024332171A5052307289 @default.
• W2024332171 hasAuthorship W2024332171A5062987908 @default.
• W2024332171 hasAuthorship W2024332171A5063110207 @default.
• W2024332171 hasAuthorship W2024332171A5069666525 @default.
• W2024332171 hasAuthorship W2024332171A5074211261 @default.
• W2024332171 hasAuthorship W2024332171A5090628379 @default.
• W2024332171 hasBestOaLocation W20243321711 @default.
• W2024332171 hasConcept C104317684 @default.
• W2024332171 hasConcept C105580179 @default.
• W2024332171 hasConcept C121608353 @default.
• W2024332171 hasConcept C142724271 @default.
• W2024332171 hasConcept C150194340 @default.
• W2024332171 hasConcept C153911025 @default.
• W2024332171 hasConcept C203014093 @default.
• W2024332171 hasConcept C204232928 @default.
• W2024332171 hasConcept C2775894508 @default.
• W2024332171 hasConcept C2776497702 @default.
• W2024332171 hasConcept C2777542201 @default.
• W2024332171 hasConcept C2781182431 @default.
• W2024332171 hasConcept C2781303241 @default.
• W2024332171 hasConcept C30481170 @default.
• W2024332171 hasConcept C502942594 @default.
• W2024332171 hasConcept C54355233 @default.
• W2024332171 hasConcept C555283112 @default.
• W2024332171 hasConcept C71924100 @default.
• W2024332171 hasConcept C7602840 @default.
• W2024332171 hasConcept C81439078 @default.
• W2024332171 hasConcept C84597430 @default.
• W2024332171 hasConcept C86803240 @default.
• W2024332171 hasConceptScore W2024332171C104317684 @default.
• W2024332171 hasConceptScore W2024332171C105580179 @default.
• W2024332171 hasConceptScore W2024332171C121608353 @default.
• W2024332171 hasConceptScore W2024332171C142724271 @default.
• W2024332171 hasConceptScore W2024332171C150194340 @default.
• W2024332171 hasConceptScore W2024332171C153911025 @default.
• W2024332171 hasConceptScore W2024332171C203014093 @default.
• W2024332171 hasConceptScore W2024332171C204232928 @default.
• W2024332171 hasConceptScore W2024332171C2775894508 @default.
• W2024332171 hasConceptScore W2024332171C2776497702 @default.
• W2024332171 hasConceptScore W2024332171C2777542201 @default.
• W2024332171 hasConceptScore W2024332171C2781182431 @default.
• W2024332171 hasConceptScore W2024332171C2781303241 @default.
• W2024332171 hasConceptScore W2024332171C30481170 @default.
• W2024332171 hasConceptScore W2024332171C502942594 @default.
• W2024332171 hasConceptScore W2024332171C54355233 @default.
• W2024332171 hasConceptScore W2024332171C555283112 @default.
• W2024332171 hasConceptScore W2024332171C71924100 @default.
• W2024332171 hasConceptScore W2024332171C7602840 @default.
• W2024332171 hasConceptScore W2024332171C81439078 @default.
• W2024332171 hasConceptScore W2024332171C84597430 @default.

• next